BCL2 and acute myeloid leukemia: When we analyzed the prognostic impact of high BCL2 expression in our cohort of AML-NK patients we have found that BCL2+ status was associated with the presence of resistant disease, since 88% of resistant patient had elevated BCL2 expression (P = 0.024).